Buy Intersect ENT Stock | XENT Stock Price & Latest News | Public
XENT

Intersect ENT

$0.00 (0.00%)Today

    About XENT

    Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.24
    -0.47
    -0.71
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.32

    Actual EPS
    Q4 2020

    Stats

    Market Cap$709,67M
    Volume4,47k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$31.46
    1 Year Low$5.97
    Open$21.57
    High$22.02
    Low$21.57

    Buy any stock with any amount of money.

    Download the App
    Download the app